GB794043A - New quinoline derivatives - Google Patents

New quinoline derivatives

Info

Publication number
GB794043A
GB794043A GB1594555A GB1594555A GB794043A GB 794043 A GB794043 A GB 794043A GB 1594555 A GB1594555 A GB 1594555A GB 1594555 A GB1594555 A GB 1594555A GB 794043 A GB794043 A GB 794043A
Authority
GB
United Kingdom
Prior art keywords
amino
phenylquinoline
methochloride
chloro
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1594555A
Inventor
Arthur Donald Ainley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB1594555A priority Critical patent/GB794043A/en
Publication of GB794043A publication Critical patent/GB794043A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

The invention comprises quinoline derivatives, which are quaternary salts, of the general formula <FORM:0794043/IV (b)/1> (wherein R and R1 may be the same or different and represent alkyl radicals, R2 represents a phenyl radical optionally bearing halogen, alkyl or alkoxy substituents, R3 and R4 both represent hydrogen or one hydrogen and the other an alkyl radical, R5 represents hydrogen, R6 hydrogen or an alkyl radical of not more than 4 carbon atoms and X an anion), and the manufacture thereof by (a) (when R=R1) treating a compound of the general formula <FORM:0794043/IV (b)/2> with a quaternary salt-forming agent RX, or (b) interaction of a compound of the formula <FORM:0794043/IV (b)/3> with a compound of the formula <FORM:0794043/IV (b)/4> (wherein Y represents a halogen atom), or (c) replacing anions other than X by X by the action of a mineral acid or salt containing the anion X. The products are useful as chemotherapeutic agents, especially for treating babesiasis. In examples: (1) 2-amino-4-chloro-6-methylpyrimidine 1-methiodide is refluxed in water with 4:6 - diamino - 2 - phenylquinoline methochloride hydrochloride and the product is treated with hydrochloric acid to give 4-amino-6 - (21 - amino - 61 - methylpyrimidyl - 41 - amino) - 2 - phenylquinoline 1:11 - dimethochloride; (2) 4-amino-6-(21-amino-61-methylpyrimidyl - 41 - amino) - 2 - phenylquinoline is heated with dimethyl sulphate in nitrobenzene to produce its 1:11-dimethosulphate, which is converted to the product of (1) by treatment with aqueous sodium chloride solution; (3) 4-amino - 6 - (21 - aminopyrimidyl - 41 - amino) - 2 - phenylquinoline is similarly converted to its dimethosulphate, which is treated with sodium iodide to produce the dimethiodide; (4) 2-amino - 4 - chloro - 6 - methylpyrimidine 1 - methiodide and 6 - amino - 4 - methylamino - 2 - phenylquinoline methochloride are refluxed in dilute hydrochloric acid to produce 4-methylamino - 6 - (21 - amino - 61 - methylpyrimidyl - 41 - amino) - 2 - phenylquinoline 1:11 - dimethochloride; (5) 4:6 - diamino - 2 - p - chlorophenylquinoline methochloride hydrochloride and 2 - amino - 4 - chloro - 6 - methylpyrimidine 1 - methiodide are refluxed in water and the reaction mixture is poured into saturated aqueous sodium chloride solution to precipitate 4-amino-6-(21-amino-61-methylpyrimidyl-41-amino) - 2 - p - chlorophenylquinoline 1:11 - dimethochloride; (6) similarly, except that hydrochloric acid is used instead of sodium chloride solution, 4:6 - diamino - 2 - p - methoxyphenylquinoline methochloride hydrochloride yields the corresponding p-methoxy compound. Starting materials. Pyrimidylaminoquinolines of the second general formula above are obtainable by interaction of the corresponding 6-aminoquinoline compounds with the corresponding 4-halopyrimidine compounds in an aqueous acid medium. The 6-aminoquinoline compounds may be prepared by ring-closing the condensation product of a p-acylaminoaniline with a compound of the formula R2.COCH2-COOR7 (where R7 is a lower alkyl radical) to form a 6-acylamino-4-hydroxyquinoline, replacing the hydroxy group by a halogen atom, e.g. by means of POCl3, reacting the product with ammonia or a monoalkylamine and subjecting the resulting 6-acylaminoquinoline compound to acid hydrolysis. The preparation of the starting materials of Examples (2) and (3) is described in detail. 4:6-Diamino-2-phenylquinoline methochloride hydrochloride is obtained by the action of dimethyl sulphate, followed by refluxing with dilute hydrochloric acid, from 6 - acetamido - 4 - amino - 2 - phenylquinoline, itself prepared as indicated above from the condensation product of p-aminoacetanilide and ethyl benzoylacetate. 6-Amino-4-methylamino-2-phenylquinoline methochloride is similarly prepared from the analogously obtained 6-acetamido - 4 - methylamino - 2 - phenylquinoline. Ethyl p-chloro- and p-methoxy-benzoylacetate similarly yield 4:6-diamino-2-p-chloro- and -p-methoxy-phenylquinoline methochloride hydrochlorides via 6-acetamido-4-hydroxy- and -4-amino-2-p-chloro- and -p-methoxyphenylquinoline.
GB1594555A 1955-06-03 1955-06-03 New quinoline derivatives Expired GB794043A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1594555A GB794043A (en) 1955-06-03 1955-06-03 New quinoline derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1594555A GB794043A (en) 1955-06-03 1955-06-03 New quinoline derivatives

Publications (1)

Publication Number Publication Date
GB794043A true GB794043A (en) 1958-04-30

Family

ID=10068383

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1594555A Expired GB794043A (en) 1955-06-03 1955-06-03 New quinoline derivatives

Country Status (1)

Country Link
GB (1) GB794043A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002036586A1 (en) * 2000-11-06 2002-05-10 Astrazeneca Ab N-type calcium channel antagonists for the treatment of pain
WO2002036567A1 (en) * 2000-11-06 2002-05-10 Astrazeneca Ab N-type calcium channel antagonists for the treatment of pain
WO2003018021A1 (en) * 2001-08-22 2003-03-06 Amgen Inc. 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002036586A1 (en) * 2000-11-06 2002-05-10 Astrazeneca Ab N-type calcium channel antagonists for the treatment of pain
WO2002036567A1 (en) * 2000-11-06 2002-05-10 Astrazeneca Ab N-type calcium channel antagonists for the treatment of pain
US6815447B2 (en) 2000-11-06 2004-11-09 Astrazeneca Ab N-type calcium channel antagonists for the treatment of pain
US7189714B2 (en) 2000-11-06 2007-03-13 Astrazeneca Ab N-type calcium channel antagonists for the treatment of pain
US7348340B2 (en) * 2000-11-06 2008-03-25 Astrazeneca Ab N-type calcium channel antagonists for the treatment of pain
WO2003018021A1 (en) * 2001-08-22 2003-03-06 Amgen Inc. 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents
US6939874B2 (en) 2001-08-22 2005-09-06 Amgen Inc. Substituted pyrimidinyl derivatives and methods of use
AU2002336390B2 (en) * 2001-08-22 2005-10-20 Amgen Inc. 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents

Similar Documents

Publication Publication Date Title
ES320295A1 (en) Procedure for the preparation of new derivatives of indol. (Machine-translation by Google Translate, not legally binding)
GB794043A (en) New quinoline derivatives
ES320729A1 (en) Procedure for the synthesis of new derivatives of antranilic acid. (Machine-translation by Google Translate, not legally binding)
GB950521A (en) Pyrimidinyl-guanazoles
GB777544A (en) Water soluble organic copper compounds and a process for their production
GB1213707A (en) Phosphorus-containing 1,2,4-oxadiazole derivatives
GB748224A (en) Improvements in or relating to bis-quaternary ammonium salts
US2655503A (en) Quaternary salts of y-stilbazolines
GB822506A (en) 2:3:4:5-tetrahydrobenzazepinium salts
US2585935A (en) Quaternary salts of pyrimidylaminocinnolines and process of preparing same
ES301710A1 (en) Procedure for the preparation of new 1,2-diaril-4-alkyl-3,5-dioxo-pirazolidines (Machine-translation by Google Translate, not legally binding)
GB1180210A (en) New Bis-Alkanolamine Derivatives and process for their Production
GB683773A (en) New quinoline derivatives
GB1109502A (en) Substituted n-benzyl-ethylenediamines
GB1123762A (en) Improved process for the production of 5-cyano-uracil compounds and new intermediate products that can be formed thereby
GB826323A (en) New triazine derivatives and a process for their production
GB1104323A (en) 3-phenylpyrrole derivatives and process for preparing the same
GB1077974A (en) Quinoline compounds and a process for their production
GB685748A (en) Improvements in or relating to isoquinoline derivatives
GB789696A (en) Process for producing acridine compounds
GB945892A (en) Phenylalanines
ES350159A1 (en) A Process for the Manufacture of Dihydro-Benzdiaz[1,4]Epines
GB744281A (en) Improvements in and relating to pyridine derivatives and the manufacture thereof
GB634818A (en) Quinoline derivatives
GB657302A (en) Improvements in and relating to the preparation of substituted aralkanolamine and derivatives thereof